Brasil Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 11 Months
About Brasil Pharmaceuticals
Brasil Pharmaceuticals Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 28 February 2023 (One year and 11 months 16 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Veera Kamisetty and Sravan Lakhineni serve as directors at the Company.
Company Details
-
Location
Visakhapatnam, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U21001AP2023PTC110452
-
Company No.
110452
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
28 Feb 2023
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Brasil Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veera Kamisetty
|
Director | 28-Feb-2023 | Current |
|
Sravan Lakhineni
|
Director | 28-Feb-2023 | Current |
Financial Performance of Brasil Pharmaceuticals.
Enhance accessibility to Brasil Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brasil Pharmaceuticals?
Unlock access to Brasil Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Enigys Solutions Private LimitedSravan Lakhineni is a mutual person
-
Valuon Farms Private LimitedSravan Lakhineni is a mutual person
-
Shriaksayasujji Farms And Foods Private Limited
Sravan Lakhineni is a mutual person
-
Hextasphere Technologies Private Limited
Sravan Lakhineni is a mutual person
-
Akshindra Agro Foods Private Limited
Sravan Lakhineni is a mutual person
-
Shriakshyasiddi Bio Medicals Private Limited
Sravan Lakhineni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Brasil Pharmaceuticals?
Unlock and access historical data on people associated with Brasil Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brasil Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brasil Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.